During the past decade, California Clinical Trials conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Clinical Trials" #1 sponsor was "Astellas Pharma Global Development, Inc." with 8 trials, followed by "Sunovion" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Neuralstem Inc." with 2 trials sponsored and "Shire" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Clinical Trials" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 4 trials as a collaborator, "Janssen Biotech, Inc." with 2 trials as a collaborator, "Alpharmagen, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cubist Pharmaceuticals LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "California Clinical Trials" are "Healthy Subjects" (5 trials), "Healthy Volunteers" (4 trials), "Pharmacokinetics of Isavuconazole" (4 trials), "Schizophrenia" (4 trials) and "Pharmacokinetics of ASP015K" (3 trials). Many other conditions were trialed in "California Clinical Trials" in a lesser frequency.

Most popular intervention types in "California Clinical Trials" are "Drug" (30 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "ASP015K" (3 trials), "Isavuconazole" (3 trials), "Lurasidone HCl" (3 trials) and "NSI-189 Phosphate" (2 trials). Other intervention names were less common.

The vast majority of trials in "California Clinical Trials" are 29 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "California Clinical Trials". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in California Clinical Trials, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in California Clinical Trials, 26 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".